Data gathered: November 27
Alternative Data for MEI Pharma
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,000 | Sign up | Sign up | Sign up |
| Google Trends | 100 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,188 | Sign up | Sign up | Sign up |
| Twitter Mentions | 18 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About MEI Pharma
MEI Pharma, Inc., an advanced stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.
| Price | $2.80 |
| Target Price | Sign up |
| Volume | 40,380 |
| Market Cap | $19M |
| Year Range | $2.67 - $4.05 |
| Dividend Yield | 0% |
| PE Ratio | 1.08 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP)November 25 - ETF Daily News |
 |
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash PositionNovember 12 - Yahoo |
 |
MEI Pharma (NASDAQ:MEIP) Stock Crosses Below 200 Day Moving Average – Here’s What HappenedOctober 30 - ETF Daily News |
|
MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.comOctober 29 - ETF Daily News |
MEI Pharma stock jumps 8% on sale of drug asset ME-344October 27 - Seeking Alpha |
|
|
MEI Pharma (NASDAQ:MEIP) Stock Price Passes Below 200-Day Moving Average – What’s Next?October 22 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 5.2M | -5.2M | -8M | -8M | |
| Q2 '24 | 0 | 26M | -26M | -18M | -7.7M | -2.760 |
| Q1 '24 | 0 | 4.6M | -4.6M | -9.1M | -9.7M | -1.370 |
| Q4 '23 | 0 | 8M | -8M | -11M | -12M | -1.660 |
| Q3 '23 | 65M | 6.5M | 59M | 56M | 55M | 8.460 |
Insider Transactions View All
| Cable Car Capital LLC filed to sell 6,000 shares at $0.1. September 25 '23 |
| Anson Management GP LLC filed to sell 9,000 shares at $0.1. September 25 '23 |
| Cable Car Capital LLC filed to buy 460,840 shares at $6.9. September 25 '23 |
| Anson Management GP LLC filed to buy 864,188 shares at $6.9. September 25 '23 |
| Cable Car Capital LLC filed to buy 428,800 shares at $6.5. September 22 '23 |
Similar companies
Read more about MEI Pharma (MEIP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of MEI Pharma?
The Market Cap of MEI Pharma is $19M.
What is MEI Pharma's PE Ratio?
As of today, MEI Pharma's PE (Price to Earnings) ratio is 1.08.
What is the current stock price of MEI Pharma?
Currently, the price of one share of MEI Pharma stock is $2.80.
How can I analyze the MEIP stock price chart for investment decisions?
The MEIP stock price chart above provides a comprehensive visual representation of MEI Pharma's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling MEI Pharma shares. Our platform offers an up-to-date MEIP stock price chart, along with technical data analysis and alternative data insights.
Does MEIP offer dividends to its shareholders?
As of our latest update, MEI Pharma (MEIP) does not offer dividends to its shareholders. Investors interested in MEI Pharma should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of MEI Pharma?
Some of the similar stocks of MEI Pharma are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.